Back to Search
EDWARD GUNTHER, MD
MD
Medical Oncology Physician
NPI: 1699729566IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
MD056848L(PA)
Education
YALE UNIVERSITY SCHOOL OF MEDICINE
Class of 1993
Research & Publications (18)
Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis.
PMID 12600942·Genes Dev·2003
7-preclinical
A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology.
PMID 11874978·FASEB J·2002
7-preclinical
The G-protein inhibitor, pertussis toxin, inhibits the secretion of brain-derived neurotrophic factor.
PMID 11098120·Neuroscience·2000
7-preclinical
Targeting the activator protein 1 transcription factor for the prevention of estrogen receptor-negative mammary tumors.
PMID 19138935·Cancer Prev Res (Phila)·2008
7-preclinical
Side chain modifications of (indol-3-yl)glyoxamides as antitumor agents.
PMID 18821257·J Enzyme Inhib Med Chem·2008
8-other
Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss.
PMID 18060046·J Clin Invest·2008
7-preclinical
Dormant Wnt-initiated mammary cancer can participate in reconstituting functional mammary glands.
PMID 17060457·Mol Cell Biol·2007
7-preclinical
Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation.
PMID 16953219·Oncogene·2007
7-preclinical
The AP-1 transcription factor regulates postnatal mammary gland development.
PMID 16678816·Dev Biol·2006
7-preclinical
P190-B Rho GTPase-activating protein overexpression disrupts ductal morphogenesis and induces hyperplastic lesions in the developing mammary gland.
PMID 16469769·Mol Endocrinol·2006
7-preclinical
A quantitative genomic expression analysis platform for multiplexed in vitro prediction of drug action.
PMID 15724147·Pharmacogenomics J·2005
8-other
Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ.
PMID 15705859·Cancer Res·2005
7-preclinical
Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro.
PMID 12869696·Proc Natl Acad Sci U S A·2003
8-other
Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis.
PMID 12498714·Cancer Cell·2002
7-preclinical
c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations.
PMID 11175856·Nat Med·2001
7-preclinical
Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene.
PMID 11059777·Cancer Res·2000
7-preclinical
Tongue-base suspension with a soft tissue-to-bone anchor for obstructive sleep apnea: preliminary clinical results of a new minimally invasive technique.
PMID 10629491·Otolaryngol Head Neck Surg·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 500 UNIVERSITY DR
HERSHEY, PA 17033 - Phone
- (717) 531-6585
Quick Facts
- NPI
- 1699729566
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 18
Are you this provider?
Claim Your Profile